| Income Statement |
| Total Revenue | 1.27B |
|
| Revenues (USD) | 1.27B |
| Cost of Revenue | 459.10M |
| Gross Profit | 807.80M |
| Operating Expenses | 422.90M |
| Research and Development Expense | 213.20M |
| Selling, General and Administrative Expense | 183.30M |
| Operating Income | 384.90M |
| Interest Expense | 37.80M |
| Income Tax Expense | 67.30M |
| Net Income | 214.60M |
| Net Income Common Stock | 214.60M |
| Net Income Common Stock (USD) | 214.60M |
| Consolidated Income | 214.60M |
| Earnings per Basic Share | 1.61 |
| Earnings per Basic Share (USD) | 1.61 |
| Earnings per Diluted Share | 1.60 |
| Earning Before Interest & Taxes (EBIT) | 319.70M |
| Earning Before Interest & Taxes (USD) | 319.70M |
| Weighted Average Shares | 133.63M |
| Weighted Average Shares Diluted | 134.29M |
| Balance Sheet |
| Cash and Equivalents | 1.26B |
| Cash and Equivalents (USD) | 1.26B |
| Trade and Non-Trade Receivables | 85.30M |
| Current Assets | 2.05B |
| Property, Plant & Equipment Net | 192.20M |
| Total Assets | 8.15B |
| Debt Current | 15.10M |
| Total Debt | 3.85B |
| Current Liabilities | 3.06B |
| Debt Non-Current | 3.83B |
| Total Liabilities | 7.92B |
| Accumulated Retained Earnings (Deficit) | -2.86B |
| Accumulated Other Comprehensive Income | 40.30M |
| Shareholders Equity | 237.30M |
| Shareholders Equity (USD) | 237.30M |
| Assets Non-Current | 6.10B |
| Total Debt (USD) | 3.85B |
| Deferred Revenue | 3.45B |
| Goodwill and Intangible Assets | 4.58B |
| Liabilities Non-Current | 4.86B |
| Trade and Non-Trade Payables | 94.40M |
| Tax Assets | 983.40M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 24.20M |
| Net Cash Flow from Financing | -285.20M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 180.80M |
| Capital Expenditure | -4.60M |
| Issuance (Purchase) of Equity Shares | -280.50M |
| Net Cash Flow from Investing | -4.60M |
| Net Cash Flow from Operations | 471.50M |
| Effect of Exchange Rate Changes on Cash | -900.00K |
| Share Based Compensation | 75.30M |